Considerations in the selection of a platelet component: Apheresis versus whole blood-derived

Transfusion Medicine Reviews

Volumn 13, Issue 4, 1999, Pages 311-322

  Chambers, L A ^a   Herman, J H ^a  

^a AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION REACTION; COST EFFECTIVENESS ANALYSIS; HUMAN; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

EID: 0032753628     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(99)80060-1     Document Type: Article

References (91)

1. Contreras M Final statement from the concensus conference on platelet transfusion Transfusion 38 1998 796 797
2. Strauss RG Clinical perspectives of platelet transfusion: defining the optimal dose J Clin Apheresis 10 1995 124 127
3. Herman JH Platelet transfusion therapy Mintz PD Practice Guidelines for Transfusion Therapy 1998 AABB Press Bethesda, MD 65 79
4. (in press) Klumpp TR Herman JH Gaughan JP Clinical consequences of alterations in platelet transfusion dose: A prospective, randomized, double-blind trial Transfusion 1999
5. Norol F Bierling P Roudot-Thoraval F Platelet transfusion: A dose response study Blood 92 1998 1448 1453
6. Hersh JK Hom EG Brecher ME Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient Transfusion 38 1998 637 644
7. Wallace E Churchill WH Surgenor DM Collection and transfusion of blood and blood components in the United States, 1994 Transfusion 38 1998 625 636
8. Sweeney JD Petrucci J Yankee R Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective Transfus Sci 18 1997 575 583
9. Zeger G Williams CT Shulman IA Single donor platelets: Can we afford to use them? Can we afford not to use them? Transfus Sci 18 1997 585 588
10. ed 18 Standards for Blood Banks and Transfusion Services 1997 American Association of Blood Banks Bethesda, MD
11. Muylle L Wouters E Peetersmans ME Febrile reactions to platelet transfusion: The effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method Transfusion 36 1996 886 890
12. Kelley DL Fegan RL Ng AT High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure Transfusion 37 1997 482 486
13. Holme S Heaton WA Moroff G Evaluation of platelet concentrates stored for 5 days with reduced plasma volume Transfusion 34 1994 39 43
14. Anderson NA Gray S Copplestone JA A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: Corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions Transfus Med 7 1997 33 39
15. Sowemimo-Coker SO Kim A Tribble E White cell subsets in apheresis and filtered platelet concentrates Transfusion 38 1998 650 657
16. Riccardi D Raspollini E Rebulla P Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats Transfusion 37 1997 528 530
17. Flegel WA Wiesneth M Stampe D Low cytokine contamination in buffy coat-derived platelet concentrates with-out filtration Transfusion 35 1995 917 920
18. Simon TL Sierra ER Ferdinando B Collection of platelets with a new cell separator and their storage in a citrate-plasticized container Transfusion 31 1991 335 339
19. Buchholz DH Squires JE Herman JH Plateletpheresis in 90- and 110-pound donors using the CS-3000 blood cell separator Transfusion 37 1997 715 718
20. Sweeney JD Holme S Stromberg RR In vitro and in vivo effects of prestorage filtration of apheresis platelets Transfusion 35 1995 125 130
21. Kao KJ Mickel M Braine HG White cell reduction in platelet concentrates and packed red cells by filtration: A multicenter clinical trial Transfusion 35 1995 13 19
22. Pisciotto PT Benson K Hume H Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients Transfusion 35 1995 498 502
23. Triulzi DJ Kickler TS Braine HG Detection and clinical significance of alpha granule membrane protein 140 expression on platelet collected by apheresis Transfusion 32 1992 529 533
24. Leach MF Aubuchon JP Effective of storage time on clinical efficacy of single-donor platelet units Transfusion 33 1993 661 664
25. Shanwell A Larsson S Aschan J A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipients Eur J Haematol 49 1992 77 81
26. (letter) Sanz C Pereira A Ordinas A Platelet activation and interval between plateletpheresis Transfusion 38 1998 515 516
27. Stohlawetz P Hergovich N Stiegler G Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin Transfusion 38 1998 24 30
28. Rinder HM Murphy M Mitchell JG Progressive platelet activation with storage: Evidence for shortened survival of activated platelets after transfusion Transfusion 31 1991 409 414
29. Sloand EM Yu M Klein HG Comparison of randomdonor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections Transfusion 36 1996 955 959
30. Bock M Gawaz MP Dietzler A Single-donor platelet concentrates: Changes of surface glycoproteins during storage Hemostasis 24 1994 230 235
31. Turner VS Hawker RJ Mitchell SG Paired in vivo and in vitro comparison of apheresis and “recovered” platelet concentrates stored for 5 days J Clin Apheresis 9 1994 189 194
32. abstr Slichter SJ Grabowski M Townsent-McCall D Prospective randomized transfusion trial to directly compared fresh and stored apheresis platelet (AP) and pooled random donor platelet concentrates (PC) in thrombocytopenic patients Blood 92 suppl 1 1998 672a
33. Legler TH Fischer I Dittmann J Frequency and causes of refractoriness in multiply transfused patients Ann Hematol 74 1997 185 189
34. Sazama K Reports of 355 transfusion-associated deaths: 1976 through 1985 Transfusion 30 1990 583 590
35. Davda RK Collins KA Kitchens CS Case report: Fatal staphylococcus aureus sepsis from single-donor platelet transfusion Am J Med Sci 307 1994 340 341
36. Heal NM Jones ME Forey J Fatal salmonella septicemia after platelet transfusion Transfusion 27 1997 2 5
37. Braine HG Kickler RS Charache P Bacterial sepsis secondary to platelet transfusion: An adverse effect of extended storage at room temperature Transfusion 26 1986 391 393
38. Hume HA Popovsky MA Benson K Hypotensive reactions: A previously uncharacterized complication of platelet transfusion? Transfusion 36 1996 904 909
39. Shiba M Tadokoro K Sawanobori M Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets Transfusion 37 1997 457 462
40. Fried MR Eastlund T Christie B Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy Transfusion 36 1996 900 903
41. Sonntag J Stiller B Walka MM Anaphylatoxins in fresh-frozen plasma Transfusion 37 1997 798 803
42. Schleuning M Bock M Mempel W Complement activation during storage of single-donor platelet concentrates Vox Sang 67 1994 144 148
43. Hetland G Mollnes TE Bergh K Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor alpha and leukotriene B4 Transfusion 38 1998 16 23
44. Scott CF Brandwein H Whitbread J Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters Blood 92 1998 616 622
45. Popovsky MA Transfusion-related acute lung injury Transfusion 35 1995 180 181
46. Silliman C Dickey WO Paterson AJ Analysis of the priming activity of lipids generated during routine storage of platelet concentrates Transfusion 36 1996 133 139
47. Sarkodee-Adoo CB Kendall JM Sidhara R The relationship between the duration of platelet storage and the development of transfusion reactions Transfusion 38 1998 229 235
48. Federowicz I Barrett BB Andersen JW Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage Transfusion 36 1996 21 28
49. Chambers LA Kruskall MD Pacini DG Febrile reactions after platelet transfusion: The effect of single versus multiple donors Transfusion 30 1990 219 221
50. Heddle NM Klama L Singer J The role of the plasma from platelet concentrates in transfusion reactions N Engl J Med 331 1994 625 628
51. Heddle NM Klama LN Griffith L A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions Transfusion 33 1993 794 797
52. Mangano MM Chambers LA Kruskall MS Limited efficacy of leukopoor platelets for the prevention of febrile transfusion reactions Am J Clin Pathol 95 1991 733 738
53. Ferrara JL The febrile platelet transfusion reaction: A cytokine shower Transfusion 35 1995 89 90
54. Stack G Snyder EL Cytokine generation in stored platelet concentrates Transfusion 34 1994 20 25
55. Weisbach V Putzo A Zingsem J Leukocyte depletion and storage of single-donor platelet concentrates Vox Sang 72 1997 20 25
56. Christensen LL Grunnet N Rudiger N Comparison of the level of cytokine mRNA in buffy coat-derived platelet concentrates prepared with or without white cell reduction by filtration Transfusion 38 1998 236 241
57. Aye MT Palmer DS Giulivi A Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage Transfusion 35 1995 117 124
58. Benson K Marks AR Karshall MJ Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors Transfusion 34 1994 432 437
59. Wagner FF Flegel WA Transfusion-associated graft-versus-host disease: Risk due to homozygous HLA haplotypes Transfusion 35 1995 284 291
60. Holland PV Prevention of transfusion-associated graft-versus-host disease Arch Pathol Lab Med 113 1989 285 291
61. Takahashi K Jiyi T Miyamoto M Analysis of risk factors for post-transfusion graft-versus-hosts disease in Japan Lancet 343 1994 700 702
62. Przepiorka D LeParc G Stovall MA Use of irradiated blood components: Practice parameter Am J Clin Pathol 106 1996 6 11
63. Dutcher JP Schiffer CA Aisner J Alloimmunization following platelet transfusion: The absence of a dose response relationship Blood 57 1981 395 398
64. Hogge DE Dutcher JP Aisner J Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion Am J Hematol 14 1983 363 369
65. Bishop JE McGrath K Wolf MM Clinical factors influencing the efficacy of pooled platelet transfusions Blood 71 1988 383 387
66. Klumpp TR Herman JH Innis S Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation Bone Marrow Transplant 17 1996 1035 1041
67. Ishida A Handa M Wakui M Clinical factors influencing posttransfusion platelet increments in patients undergoing hematopoietic progenitor cell transplantation: A prospective analysis Transfusion 38 1998 839 847
68. Klingemann HG Self S Banaji M Refractoriness to random donor platelet transfusions in patients with aplastic anemia: A multivariate analysis of data from 264 cases Br J Haematol 66 1987 115 121
69. Friedberg RC Donnelly SF Boyd JC Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization Blood 81 1993 3428 3434
70. Fauchet R Genetet B Gueguen M Transfusion therapy and HLA antibody response in patients undergoing open heart surgery Transfusion 22 1982 320 322
71. Friedman DF Lukas MB Jawad A Alloimmunization to platelets in heavily transfused patient with sickle cell disease Blood 88 1996 3216 3222
72. Gmur J von Felton A Osterwalder B Delayed alloimmunization using random single donor platelet transfusions: A prospective study in thrombocytopenia patients with acute leukemia Blood 62 1983 473 479
73. Sintnicolaas K Sizoo W Haije WG Delayed alloimmunisation by random single donor platelet transfusions Lancet 1 1981 750 754
74. Williamson LM Wimperis JZ Williamson P Bedside filtration of blood products in the prevention of HLA alloimmunisation: A prospective randomized study. Alloimmunisation Study Group Blood 83 1994 3028 3035
75. Sintnicolaas K van Marwijk KM van Prooijen HC Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A randomized prospective study Blood 85 1995 824 828
76. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusion: The Trial to Reduce Alloimmunization to Platelets Study Group N Engl J Med 33 1997 1861 1869
77. Glynn SA Schreiber GB Busch MP Demographic characteristics, unreported risk behaviors and the prevalence and incidence of viral infections: A comparison of apheresis and whole-blood donors Transfusion 38 1998 350 358
78. Schreiber GB Busch MP Kleinman SH The risk of transfusion-transmitted viral infection: The Retrovirus Epidemiology Donor Study N Engl J Med 334 1996 1685 1689
79. Kaushansky K Thrombopoietin N Engl J Med 339 1998 746 754
80. Kunz D Luley C Heim MU Transforming growth factor b is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates Transfusion 38 1998 156 159
81. Shanwell A Ringden O Wiechel B A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplat recipients Vox Sang 60 1991 23 27
82. Mair B Benson K Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets Transfusion 38 1998 51 55
83. Lee EJ Schiffer CA ABO compatibility can influence the results of platelet transfusion: Results of a randomized trial Transfusion 29 1989 384 389
84. Moroff G Garratty G Heal JM Selection of platelets for refractory patients by HLA matching and prospective crossmatching Transfusion 32 1992 633 640
85. Gelb AB Leavitt AD Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets Transfusion 37 1997 624 630
86. Ogden DM Asfour A Koller C Platelet crossmatches of single donor platelet concentrates using a latex agglutination assay Transfusion 33 1993 644 650
87. Leiby DA Kerr KL Campos JM A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites Transfusion 37 1997 259 263
88. Chiu EK Yuen KY Lie AK A prospective study of symptomatic bacteremia following platelet transfusion and of its management Transfusion 34 1994 940 941
89. Yomtovian R Lazarus HM Goodnough LT A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets Transfusion 33 1993 902 909
90. Barrett BB Anderson JW Anderson KC Strategies for the avoidance of bacterial contamination of blood components Transfusion 33 1993 228 233
91. Alvarez EE Rogge KJ Tarrand J Bacterial contamination of cellular blood components: A retrospective review at a large cancer center Ann Clin Lab Sci 25 1995 283 290